
Budget Strains Push States to Trim HIV Drug Access Under Ryan White
Budget pressures are pushing states to tighten enrollment and services in ADAPs funded by the Ryan White program, with Florida restricting income eligibility and removing Biktarvy from its formulary. Across 23 states, cost-containment measures are being implemented or considered as ADAP funding lags inflation, drug prices rise, and the expiration of enhanced ACA premium tax credits drives up insurance costs—threatening access to HIV treatment and potentially worsening health outcomes and transmission.







